I wonder how much longer this ridiculous market cap can be sustained, with the serious concerns over manufacturing. As time ticks away, so does Solagran's credibility. They need to raise cash fast to upgrade their facilities, with the RMOH identifying substantial problems with compliance.
RMOH are happy for Solagran to market their cheap complementary medicines, but they will require evidence that impurities do not pose safety risks. Many months of delays are the likely outcome.
SLA Price at posting:
0.0¢ Sentiment: Sell Disclosure: Not Held
